ArticleFrontiers in immunology2018

Interleukin-33 Contributes to the Induction of Th9 Cells and Antitumor Efficacy by Dectin-1-Activated Dendritic Cells.

Jintong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.